Simeon Pollack. The rationale for using hydroxycarbamide in the treatment of sickle cell disease” (Haematologica 2011;96:488–491). Reply. haematol [Internet]. 2011Jun.1 [cited 2024May1];96(6):e30-e30. Available from: https://haematologica.org/article/view/6004